logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Satoru Kakizaki

nho takasaki general medical center
H指数:39
被引数:5,546

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab

durvalumab联合tremelimumab治疗肝细胞癌患者淋巴细胞计数早期变化可预测临床结局

Journal of Gastroenterology and Hepatology
IF3.4
2026-10-070
OAAI
Yuichi Honma; Shigeo Shimose; Takanori Ito; Issei Saeki; Joji Tani; Takanori Matsuura; Tetsu Tomonari; Yasuto Takeuchi; Nobuhito Taniki; Kyo Sasaki; Ryu Sasaki; Takeshi Hatanaka; Satoru Kakizaki; Naoki Yoshioka; Takehito Naito; Mamiko Takeuchi; Tetsuya Yasunaka; Masahiro Sakata; Hideki Iwamoto; Tomotake Shirono; Satoshi Itano; Norikazu Tanabe; Takafumi Yamamoto; Atsushi Naganuma; Yuki Kanayama; Hisamitsu Miyaaki; Sohji Nishina; Nobuhiro Nakamoto; Motoyuki Otsuka; Tetsuji Takayama; Yuzo Kodama; Hideki Kobara; Taro Takami; Hiroki Kawashima; Takumi Kawaguchi; Masaru Harada
Trends in the Proportion of Hepatitis C Virus Antibody-Positive Patients Who Could be Considered for Direct-Acting Antiviral Therapy Identified Through Preoperative Testing for Ophthalmic Surgery: A Nationwide Multicenter Real-World Cohort Study in Japan

通过眼科手术术前检测识别出的丙型肝炎病毒抗体阳性患者中可考虑直接抗病毒治疗的患者的比例趋势：一项日本全国多中心真实世界队列研究

Hepatology Research
IF3.4
2026-09-160
OAAI
Ritsuzo Kozuka; Yoshihito Uchida; Hatsue Fujino; Akira Asai; Tatsuya Ide; Masaru Enomoto; Hiroki Tojima; Hirokazu Takahashi; Jun Inoue; Tadashi Ikegami; Yoshio Tokumoto; Mizuki Endo; Mika Horino; Ryo Sasaki; Tetsuro Shimakami; Koji Sawada; Kazuhito Kawata; Masatsugu Ohara; Kenji Nagata; Takako Inoue; Satoru Kakizaki; Masaaki Korenaga
Safety and Efficacy of Stereotactic Body Radiation Therapy in Very Elderly Patients (≥80 Years) with Solitary Hepatocellular Carcinoma

立体定向体部放射治疗在≥80岁单发肝细胞癌患者中的安全性和有效性

Cancers
IF4.4
2026-06-010
OA
Yuki Tamura; Hiroki Tojima; Daichi Takizawa; Mitsuhiko Shibasaki; Hirotaka Arai; Hiroki Kiyohara; Yukihiko Yoshimatsu; Takashi Ueno; Takashi Kosone; Toru Fukuchi; Takayoshi Suga; Shuichi Saito; Hideyuki Suzuki; Yuichi Yamazaki; Satoru Kakizaki; Toshio Uraoka
Ablation-Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma

在初始使用阿替利珠单抗/贝伐珠单抗控制疾病后，疾病进展时基于消融的挽救策略在肝细胞癌中的应用

Hepatology Research
IF3.4
2026-05-110
PRE
Kazuya Kariyama; Kazuhiro Nouso; Atsushi Hiraoka; Fujimasa Tada; Hideko Ohama; Hidenori Toyoda; Satoshi Yasuda; Toshifumi Tada; Kazunari Tanaka; Kunihiko Tsuji; Ei Itobayashi; Akemi Tsutsui; Koichi Takaguchi; Michitaka Imai; Toru Ishikawa; Takeshi Hatanaka; Yuki Kanayama; Satoru Kakizaki; Atsushi Naganuma; Yoshihide Ueda; Tomomitsu Matono; Hideyuki Tamai; Junpei Okamura; Hironori Tanaka; Yutaka Yata; Akiko Wakuta; Masatoshi Kudo; Takashi Kumada
Efficacy and Safety of Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma in the Caudate Lobe: A Comparative Study With Radiofrequency Ablation

尾状叶肝细胞癌患者立体定向体部放射治疗的疗效与安全性：与射频消融的对比研究

Hepatology Research
IF3.4
2026-04-280
PRE
Yuki Tamura; Hirotaka Arai; Hiroki Kiyohara; Yukihiko Yoshimatsu; Satoru Kakizaki; Yuki Kanayama; Takeshi Hatanaka; Atsushi Naganuma; Takashi Ueno; Satoshi Takakusagi; Toru Fukuchi; Hiroki Tojima; Yuichi Yamazaki; Kei Shibuya; Tatsuya Ohno; Toshio Uraoka
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

不可切除性肝细胞癌接受阿替利珠单抗联合贝伐珠单抗治疗后出血事件的临床特征、预测因素及抗血栓治疗的影响

Hepatology Research
IF3.4
2026-04-210
PRE
Fujimasa Tada; Atsushi Hiraoka; Hideko Ohama; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) Group
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab

肝内肿瘤负荷对接受阿替利珠单抗联合贝伐珠单抗治疗的合并肝外转移的肝细胞癌患者预后的影响

Hepatology Research
IF3.4
2026-04-100
PRE
Kazunari Tanaka; Kunihiko Tsuji; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Fujimasa Tada; Hideko Ohama; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-Life Practice Experts for HCC (RELPEC) Study Group and Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group
Long-Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus-Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study

索磷布韦/维帕他韦治疗丙型肝炎病毒相关失代偿期肝硬化的长期疗效：一项回顾性多中心队列研究

Hepatology Research
IF3.4
2026-04-010
PRE
Satoru Kakizaki; Tadashi Ikegami; Takeshi Hatanaka; Yuhei Suzuki; Takashi Hoshino; Atsushi Naganuma; Daichi Takizawa; Hirotaka Arai; Takashi Ueno; Keisuke Iizuka; Takahiro Arisaka; Yuichi Majima; Makoto Iijima; Shigeo Tano; Toshiyuki Tahara; Masahiro Araki; Toshiro Kamoshida; Yoshinari Takaoka; Hidekazu Kurata; Yukimura Fukaya; Kuniaki Fukuda; Atsuko Soeda; Takayoshi Suga; Shuichi Saito; Toru Fukuchi; Satoshi Takakusagi; Hitoshi Takagi; Katsuhiko Horiuchi; Yuki Kanayama; Toshiya Ohtake; Hiroki Tojima; Yuichi Yamazaki; Shunji Watanabe; Kouichi Miura; Naoki Morimoto; Liver Investigators in the Northern Kanto Study (LINKS) group
Lymphocyte–Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab

淋巴细胞-单核细胞比值预测接受度鲁单单抗联合曲美单抗治疗的HCC患者的生存情况

Liver International
IF5.2
2026-02-260
PRE
Tomomitsu Matono; Toshifumi Tada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Takanori Matsuura; Yoshihide Ueda; Soo Ki Kim; Hideko Ohama; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Shinya Fukunishi; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Jumpei Okamura; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the RELPEC Group and HCC 48 Group
Successful retreatment with glecaprevir/pibrentasvir after sofosbuvir/velpatasvir failure in a patient with hepatitis C-related decompensated cirrhosis complicated by hepatocellular carcinoma

在合并肝细胞癌的丙型肝炎相关失代偿期肝硬化患者中，在索磷布韦/维帕他韦治疗失败后使用glecaprevir/pibrentasvir成功再治疗

Clinical Journal of Gastroenterology
IF0.9
2026-01-011
PRE
Ogura, Minami; Naganuma, Atsushi; Kodama, Shohei; Nakajo, Keiji; Kasai, Otone; Suzuki, Yuhei; Uehara, Sanae; Hatanaka, Takeshi; Hoshino, Takashi; Kakizaki, Satoru
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B

阿特珠单抗联合贝伐珠单抗在Child-Pugh B级肝细胞癌患者中的有效性与安全性

LIVER INTERNATIONAL
IF5.2
2025-11-280
OAAI
Sasaki, Ryu; Shimose, Shigeo; Saeki, Issei; Ito, Takanori; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Miuma, Satoshi; Shirono, Tomotake; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Kanayama, Yuki; Naganuma, Atsushi; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Kawashima, Hiroki; Takami, Taro; Kawaguchi, Takumi; Miyaaki, Hisamitsu
Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

不可切除肝细胞癌患者接受阿特珠单抗联合贝伐珠单抗治疗后序贯免疫检查点抑制剂再治疗的结局

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
IF3.4
2025-11-010
OAAI
Ito, Takanori; Shimose, Shigeo; Saeki, Issei; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Ryu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Shirono, Tomotake; Kanayama, Yuki; Miyaaki, Hisamitsu; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Takami, Taro; Kawaguchi, Takumi; Kawashima, Hiroki
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease

日本过去二十年间肝细胞癌治疗结果的演变：早期病毒性疾病的改善

HEPATOLOGY RESEARCH
IF3.4
2025-11-010
OA
Kariyama, Kazuya; Nouso, Kazuhiro; Hiraoka, Atsushi; Tada, Fujimasa; Ohama, Hideko; Toyoda, Hidenori; Yasuda, Satoshi; Tada, Toshifumi; Tanaka, Kazunari; Tsuji, Kunihiko; Itobayashi, Ei; Tsutsui, Akemi; Takaguchi, Koichi; Imai, Michitaka; Ishikawa, Toru; Hatanaka, Takeshi; Kakizaki, Satoru; Naganuma, Atsushi; Ueda, Yoshihide; Matono, Tomomitsu; Tamai, Hideyuki; Okamura, Junpei; Tanaka, Hironori; Yata, Yutaka; Wakuta, Akiko; Kudo, Masatoshi; Kumada, Takashi
Identification of high-risk group for diabetes-associated hepatocellular carcinoma using noninvasive test for liver fibrosis
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
IF1.8
2025-11-010
PRE
Kariyama, Kazuya; Nouso, Kazuhiro; Hiraoka, Atsushi; Toyoda, Hidenori; Tada, Toshifumi; Tsuji, Kunihiko; Ishikawa, Toru; Hatanaka, Takeshi; Itobayashi, Ei; Takaguchi, Koichi; Tsutsui, Akemi; Naganuma, Atsushi; Yasuda, Satoshi; Kakizaki, Satoru; Tada, Fujimasa; Ohama, Hideko; Wakuta, Akiko; Shiota, Shohei; Kumada, Takashi

研究方向

暂未获取到该数据
T
Takeshi Hatanaka
H 指数:25论文数:219被引数:2,647
A
Atsushi Naganuma
H 指数:33论文数:307被引数:4,044
T
Toshifumi Tada
H 指数:54论文数:455被引数:1.3万
H
Hitoshi Takagi
H 指数:35论文数:319被引数:4,598
K
Ken Sato
H 指数:43论文数:529被引数:6,474
T
Takashi Kumada
H 指数:70论文数:719被引数:2.1万
T
Toru Ishikawa
H 指数:46论文数:522被引数:7,940
H
Hidenori Toyoda
H 指数:75论文数:783被引数:2.6万
A
Atsushi Hiraoka
H 指数:49论文数:543被引数:1.0万
K
Kazuya Kariyama
H 指数:37论文数:210被引数:4,781